Adenosine, cyclic2',3'-(hydrogen phosphate), monosodium salt (9CI) structure
|
Common Name | Adenosine, cyclic2',3'-(hydrogen phosphate), monosodium salt (9CI) | ||
---|---|---|---|---|
CAS Number | 37063-35-7 | Molecular Weight | 369.203 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C10H11N5NaO6P | Melting Point | 241-243ºC (dec.)(lit.) | |
MSDS | USA | Flash Point | N/A |
Name | adenosine-2':3'-cyclic monophosphate, sodium salt |
---|---|
Synonym | More Synonyms |
Melting Point | 241-243ºC (dec.)(lit.) |
---|---|
Molecular Formula | C10H11N5NaO6P |
Molecular Weight | 369.203 |
Exact Mass | 369.045044 |
PSA | 167.48000 |
LogP | 0.20200 |
Appearance of Characters | Powder | White |
Storage condition | −20°C |
Stability | Store in Freezer; Hygroscopic |
Water Solubility | It is soluble in DMSO, water. |
2',3'-cAMP, 3'-AMP, and 2'-AMP inhibit human aortic and coronary vascular smooth muscle cell proliferation via A2B receptors.
Am. J. Physiol. Heart Circ. Physiol. 301(2) , H391-401, (2011) Rat vascular smooth muscle cells (VSMCs) from renal microvessels metabolize 2',3'-cAMP to 2'-AMP and 3'-AMP, and these AMPs are converted to adenosine that inhibits microvascular VSMC proliferation vi... |
|
The brain in vivo expresses the 2',3'-cAMP-adenosine pathway.
J. Neurochem. 122(1) , 115-25, (2012) Although multiple biochemical pathways produce adenosine, studies suggest that the 2',3'-cAMP-adenosine pathway (2',3'-cAMP→2'-AMP/3'-AMP→adenosine) contributes to adenosine production in some cells/t... |
|
Extracellular 2',3'-cAMP-adenosine pathway in proximal tubular, thick ascending limb, and collecting duct epithelial cells.
Am. J. Physiol. Renal Physiol. 304(1) , F49-55, (2013) In a previous study, we demonstrated that human proximal tubular epithelial cells obtained from a commercial source metabolized extracellular 2',3'-cAMP to 2'-AMP and 3'-AMP and extracellular 2'-AMP a... |
Furo[3,4-d]-1,3,2-dioxaphosphole-4-methanol, 6-(6-amino-9H-purin-9-yl)tetrahydro-2-hydroxy-, 2-oxide, sodium salt, (3aR,4R,6R,6aR)-, hydrate (1:1:1) |
ADENOSINE 2':3'-CYCLIC MONOPHOSPHATESODI UM |
Adenosinecyclic-2',3'-monophosphatesodiumsalt |
adenosine sodio-2',3'-phosphate hydrate |
adenosine-2',3'-cyclic monophosphate sodium salt |
Cyclic Adenosine 2',3'-Monophosphate SodiuM Salt |
2',3'-Cyclic AMP SodiuM Salt |
Adenosine 2',3'-Cyclic Phosphate SodiuM Salt |
O2',O3'-hydroxyphosphoryl-adenosine |
Sodium (3aR,4R,6R,6aR)-4-(6-amino-9H-purin-9-yl)-6-(hydroxymethyl)tetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-2-olate 2-oxide hydrate (1:1:1) |
Adenosine-2',3'-monophosphate sodium salt |
EINECS 253-328-3 |
adenosine sodio-2',3'-phosphate |
Adenosine 2',3'-cyclic monophosphate sodium salt hydrate |
2',3'-cAMP*Na |
adenosine-2',3'-cyclomonophosphoric acid |
Adenosine 2',3'-(phosphoric acid sodium) salt |
MFCD00005757 |
(3aR,4R,6R,6aR)-4-(6-Amino-9H-purin-9-yl)-6-(hydroxymethyl)tetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-2-ol 2-oxide - sodium (1:1) |
2',3'-cAMP sodium salt |